4X4Z
Retrofitting antibodies with stabilizing mutations. Herceptin VL mutant F53D.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-08-20 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.954 |
Spacegroup name | F 2 2 2 |
Unit cell lengths | 98.580, 103.750, 110.210 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.770 - 1.800 |
R-factor | 0.1788 |
Rwork | 0.177 |
R-free | 0.21264 |
RMSD bond length | 0.021 |
RMSD bond angle | 1.984 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 37.770 | 1.900 |
High resolution limit [Å] | 1.800 | 1.800 |
Rmerge | 0.075 | 0.428 |
Number of reflections | 26083 | |
<I/σ(I)> | 7.9 | 2.4 |
Completeness [%] | 99.5 | 99.9 |
Redundancy | 3.8 | 3.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 293 | 1.1 M Sodium Malonate, 100 mM HEPES (pH 7.0), 1% (v/v) Jeffamine ED-2003 |